ED
SSYS icon

Exane Derivatives’s Stratasys SSYS Stock Holding History

Exane Derivatives’s Portfolio SSYS Stock Details SSYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-938
Closed -$22.6K – 677
2016
Q3 		$22.6K Buy
938
+37
+4% +$806 ﹤0.01% 350
2016
Q2 		$20.6K Buy
+901
New +$21.1K ﹤0.01% 330

Other funds holding SSYS

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Exane Derivatives's SSYS Position: Q4 2016 in Review

Exane Derivatives sold out of Stratasys (SSYS) in Q4 2016, closing a stake of 938 shares — an estimated $22.6K sold.

Exane Derivatives first reported a position in SSYS in Q2 2016 and held it in 2 quarters. The position peaked at $22.6K in Q3 2016. 168 funds tracked by Wall St. Rank hold SSYS as of Q4 2016.

  • Exane Derivatives reported no remaining Stratasys position as of Q4 2016 after selling out during the quarter.
  • Exane Derivatives sold 938 Stratasys shares in Q4 2016, an estimated $22.6K.
  • Exane Derivatives first reported a position in Stratasys in Q2 2016 and held it in 2 quarters.
  • Exane Derivatives's Stratasys position peaked at $22.6K in Q3 2016.
  • 168 funds tracked by Wall St. Rank held Stratasys as of Q4 2016.

Based on Exane Derivatives's 13F filing for Q4 2016, filed 27 Jan 2017.